JP2025509722A5 - - Google Patents

Info

Publication number
JP2025509722A5
JP2025509722A5 JP2024555092A JP2024555092A JP2025509722A5 JP 2025509722 A5 JP2025509722 A5 JP 2025509722A5 JP 2024555092 A JP2024555092 A JP 2024555092A JP 2024555092 A JP2024555092 A JP 2024555092A JP 2025509722 A5 JP2025509722 A5 JP 2025509722A5
Authority
JP
Japan
Prior art keywords
rasm
less
imac
preparation
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024555092A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025509722A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/064657 external-priority patent/WO2023178325A1/en
Publication of JP2025509722A publication Critical patent/JP2025509722A/ja
Publication of JP2025509722A5 publication Critical patent/JP2025509722A5/ja
Pending legal-status Critical Current

Links

JP2024555092A 2022-03-18 2023-03-17 医薬組換えヒト酸性スフィンゴミエリナーゼ組成物及び方法 Pending JP2025509722A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263321636P 2022-03-18 2022-03-18
US63/321,636 2022-03-18
PCT/US2023/064657 WO2023178325A1 (en) 2022-03-18 2023-03-17 Pharmaceutical recombinant human acid sphingomyelinase compositions and methods

Publications (2)

Publication Number Publication Date
JP2025509722A JP2025509722A (ja) 2025-04-11
JP2025509722A5 true JP2025509722A5 (cg-RX-API-DMAC7.html) 2026-03-24

Family

ID=86051983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024555092A Pending JP2025509722A (ja) 2022-03-18 2023-03-17 医薬組換えヒト酸性スフィンゴミエリナーゼ組成物及び方法

Country Status (12)

Country Link
US (1) US20230365946A1 (cg-RX-API-DMAC7.html)
EP (1) EP4493684A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025509722A (cg-RX-API-DMAC7.html)
KR (1) KR20240156645A (cg-RX-API-DMAC7.html)
CN (1) CN119365593A (cg-RX-API-DMAC7.html)
AR (1) AR128825A1 (cg-RX-API-DMAC7.html)
AU (1) AU2023235321A1 (cg-RX-API-DMAC7.html)
CA (1) CA3254814A1 (cg-RX-API-DMAC7.html)
IL (1) IL315655A (cg-RX-API-DMAC7.html)
MX (1) MX2024011382A (cg-RX-API-DMAC7.html)
TW (1) TW202403043A (cg-RX-API-DMAC7.html)
WO (1) WO2023178325A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119968454A (zh) 2022-09-28 2025-05-09 建新公司 用于生产生物产品的系统和装置及其使用方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215051A (en) 1979-08-29 1980-07-29 Standard Oil Company (Indiana) Formation, purification and recovery of phthalic anhydride
US5773278A (en) 1991-05-03 1998-06-30 Mount Sinai Medical Center Acid sphingomyelinase gene
US20020137173A1 (en) * 2001-02-05 2002-09-26 Dae-Kyong Kim Membrane-associated sphingomyelinase derived from bovine brain, isolation method therefor and anti-sphingomyelinase monoclonal anitibody
BRPI0411291A (pt) * 2003-06-12 2006-08-01 Genzyme Corp esfingomielinase acida humana modificada tendo atividade aumentada e métodos para a fabricação da mesma
WO2008085988A1 (en) 2007-01-05 2008-07-17 Amgen Inc. Methods of purifying proteins
CN101918430A (zh) 2008-01-18 2010-12-15 弗·哈夫曼-拉罗切有限公司 非糖基化蛋白质的纯化
KR20130020789A (ko) 2010-05-19 2013-02-28 에프. 호프만-라 로슈 아게 소수성 상호작용 크로마토그래피 방법
AR082319A1 (es) * 2010-07-22 2012-11-28 Biomarin Pharm Inc Produccion de una n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforilada y sus usos
US10259842B2 (en) 2013-05-15 2019-04-16 Medimmune, Llc Purification of recombinantly produced polypeptides
PL3672622T3 (pl) * 2017-08-24 2024-04-02 Genzyme Corporation Rekombinowana ludzka kwaśna sfingomielinaza do zastosowania w leczeniu nieprawidłowych stanów kości u pacjentów z niedoborem kwaśnej sfingomielinazy
EP3728287B1 (en) 2017-12-19 2024-04-10 CSL Behring Lengnau AG Protein purification and virus inactivation with alkyl glycosides
PY1939780A (es) 2018-05-25 2019-12-04 Genzyme Corp Composiciones farmacéuticas para el tratamiento de la deficiencia de esfingomielinasa ácida

Similar Documents

Publication Publication Date Title
EP1568710B1 (en) Antibody purification method
JP3262128B2 (ja) 蛋白質の精製方法
US6908749B2 (en) Method for preparing human serum albumin containing heat-treatment
KR930003665B1 (ko) 에리스로포이에틴의 정제방법
JP2022536486A5 (cg-RX-API-DMAC7.html)
US7001885B2 (en) Method for removing multimers of human serum albumin
WO2019184368A1 (zh) 一种高纯度rhNGF的制备方法
JP2025510977A5 (cg-RX-API-DMAC7.html)
EP1710250A1 (en) Method for preparing serum albumin through heat-treatment in presence of divalent cation
CN1250567C (zh) 钙离子结合蛋白的提纯方法
Davies et al. Purification of some tricarboxylic acid cycle enzymes from beef heart using affinity elution chromatography
CN112175063B (zh) 一种高效液相色谱法制备高纯度重组表皮生长因子的工艺
RU2024129669A (ru) Фармацевтические композиции на основе рекомбинантной кислой сфингомиелиназы человека и связанные способы
CN1120365C (zh) 一种新的亲和介质和用该介质纯化白蛋白的方法
WO1995004077A1 (en) Method of purifying plasminogen
JPS6160050B2 (cg-RX-API-DMAC7.html)
KR20200022052A (ko) 설파타아제 단백질을 정제하는 방법
JP2003082422A (ja) ガリウムの回収方法
JP4154743B2 (ja) インターロイキン6レセプターの精製方法
JP2945181B2 (ja) 免疫グロブリンmの精製方法
JPH05170799A (ja) ヒトインターロイキン8の精製方法
JPH11287792A (ja) インターロイキン6レセプターの精製法
CN118702802A (zh) 一种纯化重组人生长激素的方法
JPS63145297A (ja) タンパク質の精製方法
CN113024655A (zh) 一种高效去除rhNGF前体的纯化方法